Der Pharma Chemica
Journal for Medicinal Chemistry, Pharmaceutical Chemistry, Pharmaceutical Sciences and Computational Chemistry
ISSN: 0975-413X
Anjali Sharma
Department of Biotechnology, Meerut Institute of Engineering and Technology, Meerut 250005, IndiaPublications
-
Research Article
Quantitative Structure-Activity Relationship and Molecular Modeling Studies on a series of chiral tetrahydronaphthalene-fused spirooxindole as CDK4 inhibitor against Glioblastoma
Author(s): Anjali Sharma and Neeraj Agarwal*
Cyclin Dependent Kinase 4(CDK4) is responsible for the progression of cell cycle at G1-S phase. CDK inhibitor alters the cell cycle that will inhibit cancer cell formation. Spirooxindole derivative targets p53-MDM2 interaction that inhibits CDK4 protein which results in inhibition of cell cycle. Spirooxindole is a unique three- dimensional scaffold that was first isolated from Rubiaceae and Apocynaceae plants. Spriooxindole is a promising drug through many years which can be used to treat an array of diseases such as cancer, analgesic, mental disorder, bacterial and viral infection. From past decade spirooxindole became a huge topic of interest in bio medicinal field due to its multipotentability. In our present work, we have performed QSAR (Quantitative Structure-Activity Relationship) and Molecular modeling studies on a series of chiral tetrahydronaphthalene-fused spirooxindole, res.. Read More»
Select your language of interest to view the total content in your interested language
Google Scholar citation report
Citations : 15261
Der Pharma Chemica received 15261 citations as per Google Scholar report
Der Pharma Chemica peer review process verified at publons
